Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$1.6B |
| 2 |
American Express
AXP
|
+$398M |
| 3 |
Capital One
COF
|
+$151M |
| 4 |
Apollo Global Management
APO
|
+$111M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$109M |
Top Sells
| 1 |
Apple
AAPL
|
+$1.16B |
| 2 |
Microsoft
MSFT
|
+$873M |
| 3 |
Amazon
AMZN
|
+$403M |
| 4 |
NVIDIA
NVDA
|
+$356M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$283M |
Sector Composition
| 1 | Technology | 30.21% |
| 2 | Healthcare | 13.75% |
| 3 | Consumer Discretionary | 12.04% |
| 4 | Industrials | 9.22% |
| 5 | Communication Services | 8.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1751
Aurora
AUR
$10.5B
| $2.47M | ﹤0.01% |
839,500
+120,300
| +17% | +$354K |
|
1752
Pediatrix Medical
MD
$1.45B
| $2.46M | ﹤0.01% |
173,000
+2,700
| +2% | +$38.4K |
|
1753
National Beverage
FIZZ
$3.67B
| $2.46M | ﹤0.01% |
50,800
+500
| +1% | +$24.2K |
|
1754
Stewart Information Services
STC
$2.09B
| $2.46M | ﹤0.01% |
59,700
+1,100
| +2% | +$45.3K |
|
1755
Utz Brands
UTZ
$1.12B
| $2.45M | ﹤0.01% |
149,900
+10,400
| +7% | +$170K |
|
|
HTLF
1756
DELISTED
Heartland Financial USA, Inc.
HTLF
| $2.45M | ﹤0.01% |
87,900
-3,700
| -4% | -$103K |
|
1757
Arvinas
ARVN
$568M
| $2.44M | ﹤0.01% |
98,500
+900
| +0.9% | +$22.3K |
|
1758
Zeta Global
ZETA
$4.84B
| $2.44M | ﹤0.01% |
286,200
+41,800
| +17% | +$357K |
|
1759
indie Semiconductor
INDI
$770M
| $2.44M | ﹤0.01% |
259,700
+97,700
| +60% | +$918K |
|
1760
Hain Celestial
HAIN
$194M
| $2.44M | ﹤0.01% |
194,714
+2,000
| +1% | +$25K |
|
1761
MillerKnoll
MLKN
$1.4B
| $2.43M | ﹤0.01% |
164,652
+1,600
| +1% | +$23.6K |
|
1762
IDEAYA Biosciences
IDYA
$2.16B
| $2.43M | ﹤0.01% |
103,300
+20,300
| +24% | +$477K |
|
1763
Upwork
UPWK
$2.24B
| $2.42M | ﹤0.01% |
259,600
+4,400
| +2% | +$41.1K |
|
1764
Healthcare Services Group
HCSG
$1.16B
| $2.42M | ﹤0.01% |
161,963
+2,100
| +1% | +$31.4K |
|
1765
Aehr Test Systems
AEHR
$792M
| $2.42M | ﹤0.01% |
58,600
+2,200
| +4% | +$90.8K |
|
1766
Yext
YEXT
$1.07B
| $2.41M | ﹤0.01% |
213,200
| – | – |
|
1767
Rocket Pharmaceuticals
RCKT
$341M
| $2.4M | ﹤0.01% |
120,900
-6,500
| -5% | -$129K |
|
|
UNIT
1768
Uniti Group
UNIT
$1.71B
| $2.4M | ﹤0.01% |
519,474
+7,600
| +1% | +$35.1K |
|
1769
Navitas Semiconductor
NVTS
$1.31B
| $2.4M | ﹤0.01% |
227,700
+12,500
| +6% | +$132K |
|
1770
Weibo
WB
$3B
| $2.39M | ﹤0.01% |
182,523
-35,700
| -16% | -$468K |
|
1771
Scholastic
SCHL
$691M
| $2.39M | ﹤0.01% |
61,500
-2,100
| -3% | -$81.7K |
|
1772
Sprinklr
CXM
$1.88B
| $2.38M | ﹤0.01% |
172,200
+50,000
| +41% | +$692K |
|
1773
Establishment Labs
ESTA
$1.09B
| $2.37M | ﹤0.01% |
34,600
-7,400
| -18% | -$508K |
|
1774
Ichor Holdings
ICHR
$579M
| $2.37M | ﹤0.01% |
63,200
+1,100
| +2% | +$41.3K |
|
|
EVBG
1775
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $2.37M | ﹤0.01% |
88,100
+1,900
| +2% | +$51.1K |
|